Back | Next |
home / stock / ipcif / ipcif message board
Subject | By | Source | When |
---|---|---|---|
Somebody better tell the lawyers. | WeeZuhl | investorshub | 01/16/2020 8:24:38 PM |
aelmtpa- I guess I will watch where $ELTP | wimuskyfisherman | investorshub | 01/16/2020 6:41:41 PM |
Completely incorrect. | aELmTPa | investorshub | 01/16/2020 5:19:15 PM |
DR Ryan- Agreed... Opioids are not getting approved | wimuskyfisherman | investorshub | 01/16/2020 5:15:25 PM |
As predicted, opioids are a no go now | DR Ryan | investorshub | 01/16/2020 3:46:13 PM |
And the Who's in Whoville went boohoo. | willlbone | investorshub | 01/16/2020 3:04:21 PM |
Wish you the best too Fabius | wimuskyfisherman | investorshub | 01/16/2020 2:49:34 PM |
It's over folks. | fabius | investorshub | 01/16/2020 2:31:55 PM |
Sub .20 at the open tomorrow is my guess. | aELmTPa | investorshub | 01/16/2020 1:59:51 AM |
Pretty much as expected imho. I am | nsomniyak | investorshub | 01/15/2020 9:56:42 PM |
CANNED!!!!! Do you recommend approval of AXIMRIS XR (oxycodone | aELmTPa | investorshub | 01/15/2020 9:55:01 PM |
If its easier to manipulate, I really question | wimuskyfisherman | investorshub | 01/15/2020 8:41:03 PM |
It's easy to crush | WeeZuhl | investorshub | 01/15/2020 8:30:09 PM |
wimuskyfisherman - It's not at all comparable to | AnAnon123 | investorshub | 01/15/2020 6:48:42 PM |
Halted | LexTrader | investorshub | 01/15/2020 6:47:50 PM |
Fabius- How were the studies incomplete? I think | wimuskyfisherman | investorshub | 01/15/2020 6:09:05 PM |
Wim, difficult to imagine any other outcome than | fabius | investorshub | 01/15/2020 5:48:49 PM |
Fabius- If this gets voted no... I suspect | wimuskyfisherman | investorshub | 01/15/2020 5:30:45 PM |
O-did-it again ! | fabius | investorshub | 01/15/2020 4:17:12 PM |
Intellipharmaceutics will ultimately get a CRL, with the | AnAnon123 | investorshub | 01/15/2020 3:45:18 PM |
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc Company Name:
IPCIF Stock Symbol:
OTCMKTS Market:
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-re...
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release...